Bactiguard reports strong Q3 2026 financial results
Third-quarter revenue rose 20.6% to SEK 58.4 million driven by BD partnership growth, while adjusted EBITDA margin improved significantly to 34.3%
See the latest news and media coverage for Bactiguard. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical technology company specializing in infection prevention
bactiguard.comLast updated
In short: Bactiguard swung to Q3 2026 profit as revenue rose 20.6% on BD growth
Third-quarter revenue rose 20.6% to SEK 58.4 million driven by BD partnership growth, while adjusted EBITDA margin improved significantly to 34.3%
Revenue rose 20.6% to SEK 58.4 million driven by BD partnership growth, while operating profit turned positive at SEK 6.8 million.
Total revenue increased 12% excluding currency, driven by BD partnership and Wound Management growth.
Revenue fell 16% to 46.9 MSEK while costs decreased 8%. The company highlights partnership progress and regulatory updates.
Medical technology company Bactiguard reports increased turnover and a positive operating result in the third quarter, driven by strong growth in licensing operations.
Medical technology company Bactiguard reports a net income of SEK 7.3 million for the third quarter of 2026 (-7.5). Earnings per share...
Bactiguard's founder and former CEO Christian Kinch is selling his entire holding to Tombact AB, which is controlled by the company's largest shareholder Thomas von Koch.
The medical technology company Bactiguard reports a net profit of minus 8.2 million kronor for the second quarter of 2026 (minus 8.1).
Track Bactiguard and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Bactiguard and other trending companies.